| Orly Haskin, MD | |
|
300 Pasteur Dr, Room G306, Stanford, CA 94305-2200 | |
| (650) 723-7903 | |
| Not Available |
| Full Name | Orly Haskin |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Nephrology |
| Location | 300 Pasteur Dr, Stanford, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134547102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0210X | Pediatrics - Pediatric Nephrology | 129479 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Orly Haskin, MD 3390 South Ct, Palo Alto, CA 94306-3530 Ph: (650) 690-5167 | Orly Haskin, MD 300 Pasteur Dr, Room G306, Stanford, CA 94305-2200 Ph: (650) 723-7903 |
News Archive
A consortium of thirty-two researchers worldwide, led by Dr Jordi Surrallés, professor of the Department of Genetics and Microbiology at Universitat Autònoma de Barcelona (UAB) and member of the Centre for Biomedical Network Research on Rare Diseases (CIBERER), genetically and clinically characterised almost all Spanish patients suffering from Franconi anaemia, a rare disease affecting one in every 500,000 persons and which is characterised by severe anaemia in children, congenital malformations and a high predisposition to cancer.
A team of researchers from the Netherlands demonstrated that prophylactic treatment with a high dose of human convalescent plasma or by using concentrated monoclonal antibodies could protect against disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in an animal model. However, no protective effect was observed with a ten-fold lower dose of convalescent plasma. The results are currently available on the bioRxiv* preprint server.
High school students subjected to bullying and other forms of harassment are more likely to report being seriously depressed, consider suicide and carry weapons to school, according to findings from a trio of studies reported at the Pediatric Academic Societies meeting in San Diego.
About 30 years ago, Dr. Richard Sifers set out on a journey to discover why people with a rare condition known as alpha1-antitrypsin deficiency present with high variation in the severity of liver disease.
PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD's compound partnering division collaborated with Takeda to develop this product.
› Verified 1 days ago
Kathryn Gopez, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-498-7103 | |
Dr. Kathleen Gutierrez, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-5682 Fax: 650-725-8040 | |
Brittany Rae Boswell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Paden Danielle Angelo, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Angela S. Feng, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Jane Catherine Lee, M. D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Sumc - Peds Physician Billing Mc: 5530, Stanford, CA 94305 Phone: 650-498-7391 Fax: 650-725-7888 | |
Manish Ishwar Shah, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |